Predicting microRNA-disease associations from knowledge graph using tensor decomposition with relational constraints
暂无分享,去创建一个
Wen Zhang | Shichao Liu | Xiang Yue | Feng Huang | Zhouxin Yu | Zhankun Xiong | Wen Zhang | Xinran Xu | Zhouxin Yu | Zhankun Xiong | Feng Huang | Guangyan Zhang
[1] E. Miska,et al. How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.
[2] Xing Chen,et al. Ensemble of decision tree reveals potential miRNA-disease associations , 2019, PLoS Comput. Biol..
[3] É. Várallyay,et al. MicroRNA detection by northern blotting using locked nucleic acid probes , 2008, Nature Protocols.
[4] Srinivasan Parthasarathy,et al. Graph embedding on biomedical networks: methods, applications and evaluations , 2019, Bioinform..
[5] Xia Li,et al. Prediction of potential disease-associated microRNAs based on random walk , 2015, Bioinform..
[6] Hisashi Kashima,et al. Tensor factorization using auxiliary information , 2011, Data Mining and Knowledge Discovery.
[7] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[8] Xing Chen,et al. MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..
[9] Miao Zheng,et al. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM). , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] Jianye Hao,et al. A learning-based framework for miRNA-disease association identification using neural networks , 2018, bioRxiv.
[11] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[12] Bo Yu,et al. miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9 , 2019, OncoTargets and therapy.
[13] Feng Liu,et al. Predicting drug-disease associations by using similarity constrained matrix factorization , 2018, BMC Bioinformatics.
[14] Hans-Peter Kriegel,et al. A Three-Way Model for Collective Learning on Multi-Relational Data , 2011, ICML.
[15] Zhigang Zhong,et al. MiR-16 attenuates &bgr;-amyloid-induced neurotoxicity through targeting &bgr;-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer’s disease cell model , 2018, Neuroreport.
[16] Jia Wu,et al. Link Prediction with Signed Latent Factors in Signed Social Networks , 2019, KDD.
[17] Cheng Liang,et al. A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations , 2018, Bioinform..
[18] Lei Wang,et al. BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..
[19] Lars Schmidt-Thieme,et al. Learning optimal ranking with tensor factorization for tag recommendation , 2009, KDD.
[20] Inderjit S. Dhillon,et al. Large-scale Multi-label Learning with Missing Labels , 2013, ICML.
[21] T. Ochiya,et al. Novel combination of serum microRNA for detecting breast cancer in the early stage , 2016, Cancer science.
[22] Xu Zhang,et al. A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network , 2018, Genes.
[23] Xantha Karp,et al. Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.
[24] Atul Bhatnagar,et al. Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma , 2013, Clinical Cancer Research.
[25] Peizhang Xu,et al. MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.
[26] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Xing Chen,et al. Adaptive boosting-based computational model for predicting potential miRNA-disease associations , 2019, Bioinform..
[28] Feng Liu,et al. Prediction of Drug-Disease Associations and Their Effects by Signed Network-Based Nonnegative Matrix Factorization , 2018, 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[29] Tamara G. Kolda,et al. Tensor Decompositions and Applications , 2009, SIAM Rev..
[30] Guillaume Bouchard,et al. Knowledge Graph Completion via Complex Tensor Factorization , 2017, J. Mach. Learn. Res..
[31] M. Hestenes,et al. Methods of conjugate gradients for solving linear systems , 1952 .
[32] Xiangxiang Zeng,et al. Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[33] Q. Cui,et al. An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.
[34] Xing Chen,et al. MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction , 2018, PLoS Comput. Biol..
[35] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[36] Jing Li,et al. Modeling Relational Drug-Target-Disease Interactions via Tensor Factorization with Multiple Web Sources , 2019, WWW.
[37] Zenglin Xu,et al. Similarity Learning via Kernel Preserving Embedding , 2019, AAAI.
[38] Changning Liu,et al. dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.
[39] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[40] P. Manzine,et al. microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[41] Q. Cui,et al. Benchmark of computational methods for predicting microRNA-disease associations , 2019, Genome Biology.
[42] Yan Zhao,et al. NCMCMDA: miRNA-disease association prediction through neighborhood constraint matrix completion , 2020, Briefings Bioinform..
[43] George Coukos,et al. Therapeutic MicroRNA Strategies in Human Cancer , 2009, The AAPS Journal.
[44] L. Tucker,et al. Some mathematical notes on three-mode factor analysis , 1966, Psychometrika.
[45] Stephen P. Boyd,et al. Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers , 2011, Found. Trends Mach. Learn..
[46] Feng Huang,et al. A Fast Linear Neighborhood Similarity-Based Network Link Inference Method to Predict MicroRNA-Disease Associations , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[47] Xing Chen,et al. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction , 2017, PLoS Comput. Biol..
[48] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[49] Qinghua Cui,et al. MISIM v2.0: a web server for inferring microRNA functional similarity based on microRNA-disease associations , 2019, Nucleic Acids Res..
[50] Juan Fortea,et al. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations , 2017, Molecular Neurobiology.
[51] Qionghai Dai,et al. RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.
[52] M. Swellam,et al. Serum MiRNA-27a as potential diagnostic nucleic marker for breast cancer , 2019, Archives of physiology and biochemistry.
[53] Qinghua Cui,et al. The relationship of human tissue microRNAs with those from body fluids , 2020, Scientific Reports.
[54] H. Qian,et al. Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer , 2019, Experimental and therapeutic medicine.
[55] Ping Zhang,et al. Multitask Dyadic Prediction and Its Application in Prediction of Adverse Drug-Drug Interaction , 2017, AAAI.
[56] Chiang-Ching Huang,et al. MicroRNA expression profiling for Molecular Classification of pediatric brain tumors , 2011, Pediatric blood & cancer.
[57] Na-Na Guan,et al. Predicting miRNA‐disease association based on inductive matrix completion , 2018, Bioinform..
[58] Xiangxiang Zeng,et al. Prediction of potential disease-associated microRNAs using structural perturbation method , 2017, bioRxiv.